Literature DB >> 31574234

Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-κB1.

Zhengyi Ruan1, Dong Zhao1.   

Abstract

Ovarian cancer (OC) is one of the major causes of cancer-related mortality in women worldwide. Long noncoding RNAs might play a role as oncogenes or tumor suppressors. Therefore, we investigated the effect and underlying mechanisms of long intergenic noncoding RNA (LINC00) 284 on angiogenesis in OC cells. Expression of LINC00284 in OC tissues and cells was determined. Next, the interaction between LINC00284 and mesoderm-specific transcript (MEST) was evaluated. Subsequently, OC cells were transfected with overexpressed (oe)-LINC00284, silenced (si)-LINC00284, si-NF-κB1, oe-MEST, or si-MEST plasmids to investigate the underlying mechanism of LINC00284 in OC. Afterwards, the expression of matrix metalloproteinase (MMP)-2, MMP-9, B-cell lymphoma 2 (Bcl-2), Bcl-2-associated protein x (Bax), VEGF, and CD31 was determined to assess the effect of LINC00284 on OC cell proliferation, invasion, migration angiogenesis, and apoptosis. Finally, the effect of LINC00284 on tumorigenesis was investigated in nude mice models of OC. LINC00284 was highly expressed in OC. si-LINC00284 increased expression of MEST. si-LINC00284 or si-NF-κB1 led to the reduction in cell proliferation, migration, invasion, tube formation, angiogenesis, and tumorigenic ability and promoted apoptosis in OC by down-regulating MMP-2, MMP-9, Bcl-2, VEGF, and CD31 and up-regulating Bax. These effects were all reversed following the si-MEST. In vivo experiments found the same results, confirming the aforementioned findings. Taken together, LINC00284 is involved in angiogenesis during OC development by recruiting NF-κB1 and down-regulating MEST.-Ruan, Z., Zhao, D. Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-κB1.

Entities:  

Keywords:  apoptosis; mesoderm-specific transcript; proliferation; tumorigenicity

Mesh:

Substances:

Year:  2019        PMID: 31574234      PMCID: PMC6902731          DOI: 10.1096/fj.201900101RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  53 in total

1.  Linear models and empirical bayes methods for assessing differential expression in microarray experiments.

Authors:  Gordon K Smyth
Journal:  Stat Appl Genet Mol Biol       Date:  2004-02-12

Review 2.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

3.  New molecular bridge between RelA/p65 and NF-κB target genes via histone acetyltransferase TIP60 cofactor.

Authors:  Jung-Woong Kim; Sang-Min Jang; Chul-Hong Kim; Joo-Hee An; Eun-Jin Kang; Kyung-Hee Choi
Journal:  J Biol Chem       Date:  2012-01-16       Impact factor: 5.157

4.  Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.

Authors:  H Cai; X Liu; J Zheng; Y Xue; J Ma; Z Li; Z Xi; Z Li; M Bao; Y Liu
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

5.  The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro.

Authors:  Sandra M Ayuk; Heidi Abrahamse; Nicolette N Houreld
Journal:  J Photochem Photobiol B       Date:  2016-06-01       Impact factor: 6.252

6.  Loss of imprinting of PEG1/MEST in lung cancer cell lines.

Authors:  Hirofumi Nakanishi; Tetsuji Suda; Motonobu Katoh; Akiko Watanabe; Tadashi Igishi; Masahiro Kodani; Shingo Matsumoto; Masaki Nakamoto; Yasushi Shigeoka; Tetsuro Okabe; Mitsuo Oshimura; Eiji Shimizu
Journal:  Oncol Rep       Date:  2004-12       Impact factor: 3.906

7.  The NFKB1 polymorphism (rs4648068) is associated with the cell proliferation and motility in gastric cancer.

Authors:  Ying Chen; Renquan Lu; Hui Zheng; Ran Xiao; Jingjing Feng; Hongling Wang; Xiang Gao; Lin Guo
Journal:  BMC Gastroenterol       Date:  2015-02-14       Impact factor: 3.067

8.  Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer.

Authors:  Meng Zhou; Xiaojun Wang; Hongbo Shi; Liang Cheng; Zhenzhen Wang; Hengqiang Zhao; Lei Yang; Jie Sun
Journal:  Oncotarget       Date:  2016-03-15

Review 9.  Long non-coding RNAs as an epigenetic regulator in human cancers.

Authors:  Yutaka Kondo; Keiko Shinjo; Keisuke Katsushima
Journal:  Cancer Sci       Date:  2017-08-30       Impact factor: 6.716

10.  LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194.

Authors:  Jihong An; Weiling Lv; Yongzhou Zhang
Journal:  Onco Targets Ther       Date:  2017-11-10       Impact factor: 4.147

View more
  11 in total

1.  LINC00494 Promotes Ovarian Cancer Development and Progression by Modulating NFκB1 and FBXO32.

Authors:  Yang Shu; He Zhang; Jinqiu Li; Yanhong Shan
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

2.  Long intergenic non-coding RNA Linc00485 promotes lung cancer progression by modulating miR-298/c-Myc axis.

Authors:  Zhenyang Zhang; Wenwei Lin; Yuhan Lin; Mingqiang Kang; Jiafu Zhu; Zhangwei Tong; Long Wu; Jianhai Sun; Jiangbo Lin
Journal:  J Cell Mol Med       Date:  2020-11-25       Impact factor: 5.310

3.  LINC-DUBR Suppresses Malignant Progression of Ovarian Cancer by Downregulating miR-107 to Induce SMAC Expression.

Authors:  Zhehui Han; Dan Li; Yun Yang; Hong Zhang
Journal:  J Healthc Eng       Date:  2022-03-03       Impact factor: 2.682

4.  Silencing of LINC00284 inhibits cell proliferation and migration in oral squamous cell carcinoma by the miR-211-3p/MAFG axis and FUS/KAZN axis.

Authors:  Dayong Yan; Fuhua Wu; Caixia Peng; Mei Wang
Journal:  Cancer Biol Ther       Date:  2021-02-22       Impact factor: 4.742

5.  Long noncoding RNA LINC00284 facilitates cell proliferation in papillary thyroid cancer via impairing miR-3127-5p targeted E2F7 suppression.

Authors:  Bin Zhou; Yugang Ge; Qing Shao; Liyi Yang; Xin Chen; Guoqin Jiang
Journal:  Cell Death Discov       Date:  2021-06-26

6.  Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.

Authors:  Jun You; Jiayi Li; Chunlin Ke; Yanru Xiao; Chuanhui Lu; Fakun Huang; Yanjun Mi; Rongmu Xia; Qiyuan Li
Journal:  Oncogene       Date:  2021-05-28       Impact factor: 9.867

Review 7.  Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential.

Authors:  Christian T Stackhouse; G Yancey Gillespie; Christopher D Willey
Journal:  Cells       Date:  2020-10-28       Impact factor: 6.600

8.  MEST promotes bladder cancer cell proliferation, migration and invasion via STAT3/Twist-1-mediated EMT.

Authors:  Cheng Zhao; Xiheng Hu; Shiyu Tong; Miao Mo; Wei He; Long Wang; Yangle Li
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

Review 9.  Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer.

Authors:  M Poturnajova; Z Kozovska; M Matuskova
Journal:  Cell Signal       Date:  2021-08-21       Impact factor: 4.315

10.  lncRNA LINC00284 promotes nucleus pulposus cell proliferation and ECM synthesis via regulation of the miR‑205‑3p/Wnt/β‑catenin axis.

Authors:  Min Zhu; Xiaoling Yan; Yin Zhao; Huawei Xue; Zhen Wang; Bo Wu; Xiangyang Li; Yixin Shen
Journal:  Mol Med Rep       Date:  2022-03-24       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.